Journal of Pharmaceutics & Pharmacology

• Encapsulation of Isoniazid inChitosan-Gum Arabic and Poly (Lactic-Co-Glycolic Acid) PVA Particles to Provide a Sustained Release Formulation
  

Authors: Pamela Kadare, Prosper Maposa, Admire Dube and Charles Chiedza Maponga

DOI: 10.13188/2327-204X.S100001

• Evaluation of Transfersome and Protransfersome for Percutaneous Delivery of Cisplatin in Hairless Mice
  

Authors: Andang Miatmoko, Kumi Kawano, Yoshiyuki Hattori, Yoshie Maitani and Etsuo Yonemochi

DOI: 10.13188/2327-204X.S100002

• Potential for the Repurposing of Adamantanes for the Treatment of Covid-19
  

Authors: Roger F Butterworth

DOI: 10.13188/2327-204X.S200001

• Repurposing of Adamantanes for the Treatment of COVID-19: Rationale and Perspectives
  

Authors: Butterworth Roger F

DOI: 10.13188/2327-204X.S200002

• The Sars-Cov-2 Viroporin E and its Interaction with Amantadine an Analysis
  

Authors: Aranda-Abreu GE, Hernández-Aguilar ME, Herrera-Covarrubias D and Rojas-Durán F

DOI: 10.13188/2327-204X.S200003

• Lysosomotropic Action of Amantadine: Basis for Treatment of COVID-19
  

Authors: Smieszek SP, Przychodzen BP and Polymeropoulos MH

DOI: 10.13188/2327-204X.S200004

• Repurposing of Adamantanes with Transmitter Receptor Antagonist Properties for the Prevention/Treatment of COVID-19
  

Authors: Brenner SR and Butterworth RF

DOI: 10.13188/2327-204X.S200005

• Amantadine for the Treatment of SARS-Cov-2: Case Report
  

Authors: Aranda-Abreu GE1, Aranda-Martínez JD and Araújo R

DOI: 10.13188/2327-204X.S200006

• Adamantanes for the Prevention of COVID-19: A Review of Case Reports
  

Authors: Cortes Borra A

DOI: 10.13188/2327-204X.S200007

• Potential for the Use of Adamantanes for the Prevention and Treatment of the Neurological Complications of COVID-19
  

Authors: Butterworth Roger F

DOI: 10.13188/2327-204X.S200008